GlassScriptPhysician profile
Denease Francis
NPI 1043503691
$488.71
in general payments reported to CMS, 2019-2025
8 companies · $327 in 2025
The $327 reported for 2025 was more than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2022: $17.09 · 2023: $10.06 · 2024: $19.61 · 2025: $327.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $357.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $356.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ipsen Biopharmaceuticals, INC | $170.01 | 2025 | Bylvay, Iqirvo |
| Travere Therapeutics, INC. | $114.70 | 2019 | |
| Baxter Healthcare | $111.75 | 2024-2025 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care |
| Alcresta Therapeutics, INC. | $30.22 | 2025 | Relizorb |
| Alexion Pharmaceuticals, INC. | $19.49 | 2025 | Ultomiris |
| Mirum Pharmaceuticals, INC. | $17.09 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.39 | 2025 | Gattex |
| Thd America, INC. | $10.06 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denease Francis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.